When developing the chemical process of an active pharmaceutical ingredient (API), oftentimes little consideration is given to the final drug product formulation. The result of this siloed approach, however, can mean the yield of an API that is difficult to handle or requires additional processing before manufacturing the final formulation. Download this white paper to learn more about how certain physical API properties can impact drug product formulation and how creating an integrated approach may prevent roadblocks during development. | 
